Market Closed

VANI
Vivani Medical
$ 1.01
2.70%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Vivani Medical News

Latest Vivani Medical Stock News & VANI Headlines

Vivani Medical Advances Long-Acting Semaglutide Implant Toward Phase 2 Trial in 2027
3 days ago | benzinga.com
Vivani Medical Reports Third Quarter 2026 Financial Results and Provides Business Update
3 days ago | globenewswire.com
Vivani Medical Announces Participation in Upcoming Investor Conferences
2 months ago | globenewswire.com
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
3 months ago | globenewswire.com
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
4 months ago | marketbeat.com
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
4 months ago | globenewswire.com
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
4 months ago | globenewswire.com
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
5 months ago | globenewswire.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
6 months ago | globenewswire.com
Insider Buying: Vivani Medical (NASDAQ:VANI) Director Purchases $1,999,999.26 in Stock
7 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

VANI
Vivani Medical
$ 1.01
2.70%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago